- 全部删除
您的购物车当前为空
DSS30 是一种 P25/CDK5抑制剂。DSS30通过抑制淀粉样前体蛋白裂解酶1 (BACEl) 磷酸化,减少 β-淀粉样蛋白 (Aβ) 的分泌发挥作用。DSS30 可用于预防和治疗阿尔茨海默病等神经退行性疾病。


为众多的药物研发团队赋能,
让新药发现更简单!
DSS30 是一种 P25/CDK5抑制剂。DSS30通过抑制淀粉样前体蛋白裂解酶1 (BACEl) 磷酸化,减少 β-淀粉样蛋白 (Aβ) 的分泌发挥作用。DSS30 可用于预防和治疗阿尔茨海默病等神经退行性疾病。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 1,410 | In stock | |
| 2 mg | ¥ 1,980 | In stock | |
| 5 mg | ¥ 3,370 | In stock | |
| 10 mg | ¥ 4,670 | In stock | |
| 25 mg | ¥ 6,720 | In stock |
DSS30 相关产品
| 产品描述 | DSS30 is a P25/CDK5 inhibitor.DSS30 acts by inhibiting the phosphorylation of amyloid precursor protein cleaving enzyme 1 (BACEl), which reduces the secretion of β-amyloid (Aβ).DSS30 can be used for the prevention and treatment of neurodegenerative diseases such as Alzheimer's disease. |
| 体外活性 | DSS30 (50 μM, 2 h) demonstrates a maximum 50% inhibition in the P25/CDK5 complex activity, along with a reduction in the phosphorylation levels of BACE1 or Tau.[1] |
| 分子量 | 367.87 |
| 分子式 | C16H14ClNO3S2 |
| CAS No. | 883027-32-5 |
| Smiles | CC=1C=2C(SC1S(NC3=C(OC)C=CC=C3)(=O)=O)=CC=C(Cl)C2 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| 溶解度信息 | DMSO: 10 mg/mL (27.18 mM), Sonication is recommended. | |||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||
评论内容